a randomized prospective double blind study was performed to assess the ability of a transdermal therapeutic system ( tts ) delivering estradiol ( e2 ) to suppress hot flashes ( hfs ) in symptomatic postmenopausal women .
C0014912
estradiol
C0600142
hot flashes